General
Pfizer says trials show COVID-19 antiviral pill cuts hospitalisation and death risk by nearly 90 per cent
Pfizer says its experimental antiviral pill for COVID-19 cut rates of hospitalisation and death by nearly 90 per cent in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.
Key points:
- Pfizer says preliminary results of its study show its…
Continue Reading
-
General24 hours agoLive updates: Jess Hull, Nicola Olyslagers, Eleanor Patterson in action at World Athletics Championships 2025 in Tokyo Day nine
-
General23 hours agoMultiple people hospitalised after bus and car crash on busy M2 in Sydney’s north-west
-
General23 hours agoSA opposition promises to slash public transport fares to 50 cents, if elected next year
-
General20 hours agoCan recognising the state of Palestine achieve a two-state solution as Israel continues bombing Gaza?